摘要
自2019年12月底至今,全球爆发了由SARS-CoV-2引起的COVID-19肺炎大流行,中国的医生、医院、学者对COVID-19肺炎的诊断和治疗做出了大量的研究和实践。中国国家卫生健康委采取了一系列有效诊断和治疗措施,2020年1月16日至2020年3月3日,先后发布了七个《新型冠状病毒感染的肺炎诊疗方案》,这对加强对病例的早期发现,早期治疗,提高救治的能力,减少疾病的传播,提高治愈率,降低病亡率,起到了关键的作用。本研究纵向解读和分析了各试行版本之间对于COVID-19肺炎的研究进展,探讨了中国中医药的介入,以期为深度理解各个诊疗方案版本的演化、治疗方案制定和中成药的介入的提供科学的理解。
From the end of December 2019 to today,there has been a global outbreak of COVID-19 pneumonia caused by SARS-CoV-2.Chinese doctors,hospitals and scholars have made a lot of research and Practice on the diagnosis and treatment of COVID-19 pneumonia.The National Health Commission of the People’s Republic of China has taken a series of effective diagnosis and treatment measures.Seven COVID-19 pneumonia diagnosis and treatment programs were released from January 16,2020 to March 3,2020,which played a key role in strengthening early detection,early treatment,improving the ability of treatment,reducing the spread of disease,improving the cure rate and reducing the mortality.This study vertically interprets and analyzes the research progress of COVID-19 pneumonia among the trial versions,and discusses the intervention of Chinese traditional medicine,so as to provide a scientific understanding for the in-depth understanding of the evolution of each diagnosis and treatment program version,the formulation of treatment plan and the intervention of Chinese patent medicine.
作者
肖娟
龚放华
Xiao Juan;Gong Fanghua(The First-Affiliated Hospital of Hunan Normal University,Department of Neurology,Hunan Provincial People’s Hospital,Changsha,410016)
出处
《基因组学与应用生物学》
CAS
CSCD
北大核心
2020年第7期3407-3410,共4页
Genomics and Applied Biology
基金
《基因组学与应用生物学》编辑部及海南省生物工程协会《新冠肺炎的临床研究与管控策略》专项基金(项目编号20200124)资助。
关键词
SARS-CoV-2
COVID-19
诊断和治疗
诊疗方案
中成药介入
SARS-CoV-2
COVID-19
Diagnosis and treatment of COVID-19
Plan of diagnosis and treatment
intervention of Chinese patent medicine
